Intelligent Bio Solutions Expands Global Reach with Multilingual Digital Strategy
TL;DR
INBS gains competitive edge with multilingual websites for key markets.
INBS launches Arabic, Italian, and Spanish websites to expand globally.
INBS's non-invasive drug testing improves workplace safety worldwide.
INBS's fingerprint sweat-based screening system offers innovative drug testing solutions.
Found this article helpful?
Share it with your network and spread the knowledge!
Intelligent Bio Solutions (NASDAQ: INBS) is accelerating its international expansion by launching multilingual websites targeting Latin America, the Middle East, and Southern Europe. The strategic digital rollout aims to remove communication barriers and support the company's global sales objectives for its innovative workplace drug screening technology.
The company's flagship product, a fingerprint sweat-based drug screening system, is currently deployed by over 450 clients across 24 countries. By introducing Arabic, Italian, and Spanish websites, INBS can now digitally engage with potential customers representing more than 1.4 billion people in high-potential markets.
This expansion aligns with growing global demand for non-invasive workplace drug testing and compliance solutions. The move positions INBS to capitalize on emerging market opportunities and potentially increase its international client base before its planned U.S. market launch in 2025.
The multilingual strategy demonstrates the company's commitment to accessible, technologically advanced medical testing solutions that can transcend language and geographical barriers. By making its digital platforms more inclusive, INBS is strategically expanding its potential market reach and positioning itself for future growth in the rapidly evolving medical technology sector.
Curated from InvestorBrandNetwork (IBN)
